Kalkidan joined the END Fund in May 2021 and serves as Director, Programs. In this role, Kalkidan oversees the END Fund’s investment in Ethiopia, particularly focusing on the Deworming Innovation Fund.
Prior to joining the END Fund, Kalkidan worked for the Ethiopian Public Health Institute (EPHI) as a public health researcher for over 9 years. He has supported the Ethiopian Federal Ministry of Health’s since the launch of the national Neglected Tropical Diseases program. Kalkidan was involved in the nationwide mapping of schistosomiasis and STHs, LF and podoconiosis, and onchocerciasis. Since 2015, he coordinated the monitoring and evaluation of the national schistosomiasis and STH control program through sentinel schools in the country. Recently, Kalkidan led a multi-faceted project with an objective to determine cost-effectiveness of transmission break of Schistosomiasis and STHs. The project, known as “Geshiyaro”, targets more than 2 million people in Wolayita zone, SNNP region.
Kalkidan holds a Masters and Bachelors of Science in Medical parasitology and applied biology from Addis Ababa University. He also has BSc in Pharmacy from Central Health College (now Rift Valley University). In addition, he received a two year training certificate from London School of Hygiene and Tropical Medicine in collaboration with EPHI on operational research and coaching of analysts (ORCA). In his spare time, Kalkidan enjoys playing soccer and learning new languages.